DREADD Modulation of Transplanted DA Neurons Reveals a Novel Parkinsonian Dyskinesia Mechanism Mediated by the Serotonin 5-HT6 Receptor
(2016) In Neuron 90(5). p.955-968- Abstract
Transplantation of DA neurons is actively pursued as a restorative therapy in Parkinson's disease (PD). Pioneering clinical trials using transplants of fetal DA neuroblasts have given promising results, although a number of patients have developed graft-induced dyskinesias (GIDs), and the mechanism underlying this troublesome side effect is still unknown. Here we have used a new model where the activity of the transplanted DA neurons can be selectively modulated using a bimodal chemogenetic (DREADD) approach, allowing either enhancement or reduction of the therapeutic effect. We show that exclusive activation of a cAMP-linked (Gs-coupled) DREADD or serotonin 5-HT6 receptor, located on the grafted DA neurons, is sufficient to induce... (More)
Transplantation of DA neurons is actively pursued as a restorative therapy in Parkinson's disease (PD). Pioneering clinical trials using transplants of fetal DA neuroblasts have given promising results, although a number of patients have developed graft-induced dyskinesias (GIDs), and the mechanism underlying this troublesome side effect is still unknown. Here we have used a new model where the activity of the transplanted DA neurons can be selectively modulated using a bimodal chemogenetic (DREADD) approach, allowing either enhancement or reduction of the therapeutic effect. We show that exclusive activation of a cAMP-linked (Gs-coupled) DREADD or serotonin 5-HT6 receptor, located on the grafted DA neurons, is sufficient to induce GIDs. These findings establish a mechanistic link between the 5-HT6 receptor, intracellular cAMP, and GIDs in transplanted PD patients. This effect is thought to be mediated through counteraction of the D2 autoreceptor feedback inhibition, resulting in a dysplastic DA release from the transplant.
(Less)
- author
- Aldrin-Kirk, Patrick
LU
; Heuer, Andreas
LU
; Wang, Gang
LU
; Mattsson, Bengt
LU
; Lundblad, Martin
LU
; Parmar, Malin
LU
and Björklund, Tomas LU
- organization
- publishing date
- 2016-06-01
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Neuron
- volume
- 90
- issue
- 5
- pages
- 14 pages
- publisher
- Cell Press
- external identifiers
-
- pmid:27161524
- wos:000378523900010
- scopus:84964928610
- ISSN
- 0896-6273
- DOI
- 10.1016/j.neuron.2016.04.017
- language
- English
- LU publication?
- yes
- id
- 1304dee6-5532-4c6a-b5ff-6dc2cb44636e
- date added to LUP
- 2016-07-25 13:56:03
- date last changed
- 2025-01-11 09:31:48
@article{1304dee6-5532-4c6a-b5ff-6dc2cb44636e, abstract = {{<p>Transplantation of DA neurons is actively pursued as a restorative therapy in Parkinson's disease (PD). Pioneering clinical trials using transplants of fetal DA neuroblasts have given promising results, although a number of patients have developed graft-induced dyskinesias (GIDs), and the mechanism underlying this troublesome side effect is still unknown. Here we have used a new model where the activity of the transplanted DA neurons can be selectively modulated using a bimodal chemogenetic (DREADD) approach, allowing either enhancement or reduction of the therapeutic effect. We show that exclusive activation of a cAMP-linked (Gs-coupled) DREADD or serotonin 5-HT6 receptor, located on the grafted DA neurons, is sufficient to induce GIDs. These findings establish a mechanistic link between the 5-HT6 receptor, intracellular cAMP, and GIDs in transplanted PD patients. This effect is thought to be mediated through counteraction of the D2 autoreceptor feedback inhibition, resulting in a dysplastic DA release from the transplant.</p>}}, author = {{Aldrin-Kirk, Patrick and Heuer, Andreas and Wang, Gang and Mattsson, Bengt and Lundblad, Martin and Parmar, Malin and Björklund, Tomas}}, issn = {{0896-6273}}, language = {{eng}}, month = {{06}}, number = {{5}}, pages = {{955--968}}, publisher = {{Cell Press}}, series = {{Neuron}}, title = {{DREADD Modulation of Transplanted DA Neurons Reveals a Novel Parkinsonian Dyskinesia Mechanism Mediated by the Serotonin 5-HT6 Receptor}}, url = {{http://dx.doi.org/10.1016/j.neuron.2016.04.017}}, doi = {{10.1016/j.neuron.2016.04.017}}, volume = {{90}}, year = {{2016}}, }